# A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

> **NCT05645900** · PHASE3 · COMPLETED · sponsor: **Ab&B Bio-tech Co., Ltd.JS** · enrollment: 2772 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Quadrivalent influenza virus subunit vaccine
- **BIOLOGICAL:** Quadrivalent influenza virus subunit vaccine
- **BIOLOGICAL:** Quadrivalent split influenza virus vaccine

## Key facts

- **NCT ID:** NCT05645900
- **Lead sponsor:** Ab&B Bio-tech Co., Ltd.JS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-06
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-10-13
- **Target enrollment:** 2772 (ACTUAL)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645900, "A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05645900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*